105
Participants
Start Date
August 26, 2022
Primary Completion Date
February 26, 2024
Study Completion Date
February 26, 2024
Difelikefalin 1 mg Oral Tablet
Difelikefalin 1 mg medication taken orally 1 time/day
Placebo Oral Tablet
Placebo tablet taken orally 1 time/day
Cara Therapeutics Study Site, Sarandí
Cara Therapeutics Study Site, San Nicolás
Cara Therapeutics Study Site, New York
Cara Therapeutics Study Site, Ferrol
Cara Therapeutics Study Site, Pavia
Cara Therapeutics Study Site, Orangeburg
Cara Therapeutics Study Site, Brunswick
Cara Therapeutics Study Site, Miami Lakes
Cara Therapeutics Study Site, Miami Lakes
Cara Therapeutics Study Site, Miami
Cara Therapeutics Study Site, Weston
Cara Therapeutics Study Site, Modena
Cara Therapeutics Study Site, Sugar Land
Cara Therapeutics Study Site, Northridge
Cara Therapeutics Study Site, Ciudad Autonoma de Buenos Aire
Cara Therapeutics Study Site, Corrientes
Cara Therapeutics Study Site, Lanús
Cara Therapeutics Study Site, Mar del Plata
Cara Therapeutics Study Site, Adelaide
Cara Therapeutics Study Site, Camperdown
Cara Therapeutics Study Site, Concord
Cara Therapeutics Study Site, Gosford
Cara Therapeutics Study Site, Kogarah
Cara Therapeutics Study Site, Launceston
Cara Therapeutics Study Site, Liverpool
Cara Therapeutics Study Site, Melbourne
Cara Therapeutics Study Site, Saint Albans
Cara Therapeutics Study Site, Westmead
Cara Therapeutics Study Site, Belo Horizonte
Cara Therapeutics Study Site, Salvador
Cara Therapeutics Study Site, São Bernardo do Campo
Cara Therapeutics Study Site, São José do Rio Preto
Cara Therapeutics Study Site 2, São Paulo
Cara Therapeutics Study Site, São Paulo
Cara Therapeutics Study Site, Dobrich
Cara Therapeutics Study Site, Gabrovo
Cara Therapeutics Study Site, Montana
Cara Therapeutics Study Site, Plovdiv
Cara Therapeutics Study Site, Heilbronn
Cara Therapeutics Study Site, Kaiserslautern
Cara Therapeutics Study Site, Baja
Cara Therapeutics Study Site, Budapest
Cara Therapeutics Study Site, Kistarcsa
Cara Therapeutics Study Site, Pécs
Cara Therapeutics Study Site, Florence
Cara Therapeutics Study Site, Roma
Cara Therapeutics Study Site, Aguas Calientes
Cara Therapeutics Study Site, Durango
Cara Therapeutics Study Site, Guadalajara
Cara Therapeutics Study Site, Mérida
Cara Therapeutics Study Site, Golub-Dobrzyń
Cara Therapeutics Study Site, Katowice
Cara Therapeutics Study Site 2, Krakow
Cara Therapeutics Study Site, Krakow
Cara Therapeutics Study Site, Lodz
Cara Therapeutics Study Site, Szczecin
Cara Therapeutics Study Site, Wroclaw
Cara Therapeutics Study Site, Bucharest
Cara Therapeutics Study Site, Oradea
Cara Therapeutics Study Site, Timișoara
Cara Therapeutics Study Site, Daegu
Cara Therapeutics Study Site 2, Goyang-si
Cara Therapeutics Study Site, Goyang-si
Cara Therapeutics Study Site, Seoul
Cara Therapeutics Study Site, Badalona
Cara Therapeutics Study Site, Barcelona
Cara Therapeutics Study Site, Madrid
Cara Therapeutics Study Site, Palma de Mallorca
Cara Therapeutics Study Site 2, Valencia
Cara Therapeutics Study Site, Valencia
Cara Therapeutics Study Site, Vitoria-Gasteiz
Cara Therapeutics Study Site, Joinville
Cara Therapeutics Study Site, São Paulo
Cara Therapeutics Study Site, Seoul
Cara Therapeutics Study Site, Almería
Lead Sponsor
Cara Therapeutics, Inc.
INDUSTRY